Clinical Trials Logo

Filter by:
NCT ID: NCT03881800 Completed - Clinical trials for Ceftazidime Treatment

Ceftazidime in Burn Children

CEFTAZOPTIM
Start date: February 19, 2020
Phase:
Study type: Observational

Concentrations and effects of Ceftazidime in critically ill burn children are unpredictable and the risk of under-exposure may be associated with poor clinical outcomes. In addition, between-subject variability (BSV) is known to be substantial in critically ill burn children. Optimization of Ceftazidime dosing is therefore desirable for all. The investigators aim to investigate, using a population approach, the pharmacokinetics (PK) of Ceftazidime including PK/pharmacodynamic (PD) targets (fT(%) > minimal inhibitory concentration (MIC)) and PD endpoints (clinical outcomes) in critically ill burn children. The effects of covariates on Ceftazidime PK and PK/PDs are investigated in order to better explain the BSV and to ultimately suggest individualized dosage regimens. It will be a prospective PK study. Six blood samples were taken from each patient during dosing interval. The primary PK/ PD targets were Ceftazidime concentrations above the MIC of the pathogen at both 50% (50% f T>MIC) and 100% (100% f T>MIC) of the dosing interval. The investigators used skewed logistic regression to describe the effect of Ceftazidime exposure on patient outcome.

NCT ID: NCT03881683 Completed - Ovarian Cancer Clinical Trials

Determination of the Feasibility of Tumoural Somatic Mutations Detection in Blood of Patients With Ovarian Cancer

BOVARY Pilot
Start date: February 21, 2020
Phase: N/A
Study type: Interventional

BOVARY-Pilot is a monocentric prospective transversal pilot study with a total duration of 6 months. The purpose of this study is to determine the feasibility of detecting somatic tumor mutations in the blood of patients with ovarian cancer in order to determine whether a blood test can replace a tissue biopsy to prescribe a personalized treatment. The method will consist of a single blood sample during the patient's visit and prior to the establishment of any newly diagnosed cancer treatment. The concordance of somatic mutations (SNV) found in tissue and in cell-free DNA (cfDNA) extracted from blood will then be compared

NCT ID: NCT03881436 Completed - Clinical trials for Inflammatory Bowel Disease

Assessment of MRI Tractography for Pelvic Floor Sphincter Analysis

TractoCA
Start date: August 12, 2019
Phase: N/A
Study type: Interventional

Urinary and faecal incontinences generally come from a dysfunction of the pelvic floor muscles, and more particularly the sphincters. Among other causes, they may be related to accidental trauma, obstetric or iatrogenic. On this last point, the incidence of surgical interventions on the bladder collar and on the anal canal on the prevalence of incontinences can be underlined. MRI tractography could be an interesting tool to visualize in 3D the structure of pelvic sphincters and their lesions. It may thereby establish the link with observed dysfunctions, thus potentially providing a complement to the urological and proctographic examinations already carried out. The objective of this study is, first, to define the sensitivity of the MRI tractography for the visualization of the pelvic sphincters architecture regardless of the gender. In a second time, it will give a description of normal and abnormal (pathological cases) tractography, as well as a descriptive post-surgery. The other interest of this study is the assessment of the information provided by pelvic sphincters tractography on a panel of various and frequently encountered situations in clinical routine at the IHU.

NCT ID: NCT03878823 Completed - Clinical trials for Metastatic Breast Cancer

Safety and Pharmacokinetics of ODM-209

STESIDES
Start date: April 17, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this first-in-human study is to evaluate safety and tolerability of ODM-209 and find the dose of ODM-209.

NCT ID: NCT03878433 Completed - Melasma Clinical Trials

Oral Superoxide Dismutase (GLISODin) to Decrease Melasma Severity.

Glisodin
Start date: April 1, 2019
Phase: N/A
Study type: Interventional

Oxidative stress has been reported to play a role in melasma pathophysiology. The objective of the study is to compare oral superoxide dismutase (GLISODin) to placebo, in combination to sunscreen to decrease melasma severity.

NCT ID: NCT03878420 Completed - Clinical trials for Dry Age-related Macular Degeneration

Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE II)

Start date: February 14, 2019
Phase: N/A
Study type: Interventional

This LIGHTSITE II study is a double-masked, sham-controlled, parallel design, prospective multi-site study for the use of PBM as a treatment for visual impairment in subjects with dry AMD.

NCT ID: NCT03878251 Completed - Clinical trials for Attention Deficit in Intellectual Disability

Outcomes Measures in Intellectual Disability

EVALDI
Start date: July 7, 2021
Phase: N/A
Study type: Interventional

Objective quantitative primary endpoints are lacking in Clinical trials in intellectual disability. We propose to develop quantitative interactive attention evaluation criteria in patients with intellectual disability by using games on touchscreen and or eye tracking.

NCT ID: NCT03878173 Completed - Clinical trials for Post-extraction Lip or Cheek Biting Injury (PEBI)

Evaluation of Post-operative Discomforts in Children After Extraction of Temporary Teeth

DEXTRAFANT
Start date: April 1, 2016
Phase:
Study type: Observational

This prospective observational study aim to evaluate discomforts after extraction of temporary tooth under local anesthesia. The first objective is to describe the prevalence of the post-extraction pain (PEP), post-extraction bleeding (PEB), post-extraction biting injury (PEBI) in children, and the analgesic usage. The secondary objective is to define whether it is possible to determine a profile of patients or a type of extraction's procedure predictive to PEP and administration of analgesics, PEB or PEBI.

NCT ID: NCT03877978 Completed - Acute Kidney Injury Clinical Trials

Acute Kidney Attack in Severe Traumatized Patients

NEPHROTRAUMA
Start date: May 16, 2019
Phase:
Study type: Observational

Acute Kidney Injury (AKI) is a common complication of severe traumatized patients. The diagnosis is often delayed. The Nephrocheck® test allows an earlier assessment of renal stress. The objective of our study is to determine the incidence of risk of AKI in severe traumatized patients within the first 24 hours after their admission to our trauma center. The risk of AKI is defined by a NephroCheck® test >0.3

NCT ID: NCT03877900 Completed - Neonatal Death Clinical Trials

A Feasibility Study of Virtopsy With Tissue Sampling in Besancon University Hospital

VIRTOPSY+
Start date: February 28, 2019
Phase:
Study type: Observational [Patient Registry]

The aim of this project is to assess the feasibility of a new local post mortem procedure at Besançon University Hospital : Virtopsy+, magnetic resonance (MR) imaging with tissue sampling of the fetus and newborns.